Want to see AU:ICR full AI Analyst Report?
ICR Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume735.25K
Average Volume (3M)1.91M
Market Cap
AU$15.74M
Enterprise ValueAU$0.00
Total Cash (Recent Filing)AU$1.05M
Total Debt (Recent Filing)AU$1.09M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding715,306,760
10 Day Avg. Volume3,223,113
30 Day Avg. Volume1,908,177
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-3.27
Price to Sales (P/S)2.85
P/FCF Ratio-1.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~45% revenue growth signals improving product-market fit and demand in the healthcare information niche. Over the next 2-6 months this growth supports operating leverage potential, gives management more runway to validate unit economics, and underpins scaled investment in sales and product development if sustained.
Reduced LossesProgressive reduction in net losses reflects execution on cost control and revenue mix improvements. Persisting improvement indicates the business is moving toward a structurally smaller loss gap, which can extend runway, lower near-term funding needs, and create a clearer pathway to break-even if trends continue.
Lean Operating StructureA very small headcount implies a lean fixed-cost base and operational flexibility, allowing management to allocate scarce capital to product and customer acquisition. In software-driven healthcare services this can enable scalable revenue per employee and faster marginal profitability as sales scale.
Bears Say
Negative Gross ProfitPersistent negative gross profit shows unit economics are currently unprofitable, meaning core costs exceed revenue on delivered services. This structural issue requires either meaningful price recovery, cost redesign or materially higher volumes to restore sustainable margins and support long-term profitability.
Ongoing Cash BurnMaterial negative operating cash flow indicates the business consumes cash faster than it generates, creating recurring funding needs. Over months this undermines strategic optionality, increases likelihood of dilutive capital raises or costly financing, and constrains investment in growth or product development.
Negative Equity / Balance-Sheet RiskNegative shareholders' equity reflects cumulative losses that have eroded the capital base, limiting borrowing capacity and raising solvency and funding risk. This structural weakness increases dependency on external capital and could force unfavorable financing terms or operational cutbacks if results do not improve.
InteliCare Holdings Limited News
ICR FAQ
What was InteliCare Holdings Limited’s price range in the past 12 months?
InteliCare Holdings Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is InteliCare Holdings Limited’s market cap?
InteliCare Holdings Limited’s market cap is AU$15.74M.
When is InteliCare Holdings Limited’s upcoming earnings report date?
InteliCare Holdings Limited’s upcoming earnings report date is Sep 02, 2026 which is in 57 days.
How were InteliCare Holdings Limited’s earnings last quarter?
InteliCare Holdings Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is InteliCare Holdings Limited overvalued?
According to Wall Street analysts InteliCare Holdings Limited’s price is currently Overvalued.
Does InteliCare Holdings Limited pay dividends?
InteliCare Holdings Limited does not currently pay dividends.
What is InteliCare Holdings Limited’s EPS estimate?
InteliCare Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InteliCare Holdings Limited have?
InteliCare Holdings Limited has 715,306,760 shares outstanding.
What happened to InteliCare Holdings Limited’s price movement after its last earnings report?
InteliCare Holdings Limited reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of InteliCare Holdings Limited?
Currently, no hedge funds are holding shares in AU:ICR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InteliCare Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
―
20 days / 200 days
Momentum
136.36%
12-Months-Change
Fundamentals
Return on Equity
-578.72%
Trailing 12-Months
Asset Growth
-14.68%
Trailing 12-Months
Company Description
InteliCare Holdings Limited
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Australia's aged care and health industries. Among its key offerings are InteliLiving, tailored to assist seniors and individuals with disabilities, and a specialized monitoring system designed for the elderly and other vulnerable populations.
Technical Analysis
Tali Digital
―
Global Health Limited
―
Singular Health Group Ltd
―
Emyria Ltd
―
HitIQ Limited
―